Portfolio company
Balance Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This pharmaceutical company develops small molecule therapies to treat cognitive deficits and sleep disorders for patients with Down syndrome, Alzheimer's disease and narcolepsy.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cognition Therapeutics
This company develops oral small-molecule medications for patients with neurodegenerative disorders such as Alzheimer's disease and dementia with Lewy bodies.
Rodin Therapeutics
This biotechnology company develops small molecule therapies targeting epigenetic mechanisms to treat neurodegenerative and cognitive disorders for patients with diseases like Alzheimer's.
Tetra Therapeutics
This biotechnology company develops therapeutic drugs for patients suffering from neurological conditions such as Alzheimer's disease and Fragile X syndrome.
DAMONA Pharmaceuticals
This company develops small molecule therapeutics to restore cognitive function for patients with neurological and psychiatric disorders.
CuraSen Therapeutics
This biopharmaceutical company develops small molecule drugs to treat patients with neurodegenerative disorders, such as Parkinson's and Alzheimer's disease.
IAMA Therapeutics
This company develops small molecule drugs to treat neurodevelopmental and central nervous system disorders for patients with autism and epilepsy.
Pharmasum Therapeutics
This company develops neurological drugs for patients with dementia, Alzheimer's disease and Down syndrome to provide to the global healthcare market.
PharmatrophiX
The company develops small-molecule therapies targeting neurotrophin receptors for patients with Alzheimer's disease and other neurodegenerative disorders.
